Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?| Positive | ||
| Negative | ||
| Uncertain | ||
| Constraining | ||
| Legalese | ||
| Litigous | ||
| Readability |
H.S. junior Avg
|
|
New words:
abetted, absorb, accuracy, acuity, albumin, alkaline, ALP, ameliorate, American, antagonist, appraisal, asfotase, assign, AstraZeneca, ATTRm, ATTRwt, automatic, automatically, ballot, beneficiary, Berger, Bidco, bioavailability, bispecific, bridge, CCPA, Certificate, certified, cGLP, chemical, choice, circular, circulating, congressional, context, CPRA, Del, Delta, depositary, depository, dermatology, devoted, digestive, dissemination, divest, divestiture, doctrine, document, duty, dyscrasia, dysfunction, endothelial, England, enjoining, eventually, expressly, fatal, fiduciary, flaccid, forum, fosdenopterin, glomerulonephropathy, Goldman, hereof, HREC, HSCT, HSR, ICs, IDMC, incentive, incident, injection, insult, issuable, IVH, Kent, Kr, lifelong, LLC, lowest, master, McKenzie, median, MFN, misfolded, mobilize, Morgan, motivate, motivating, Naquin, Nasdaq, neuropathy, noncontrolling, notably, NTproBNP, NULIBRY, nurse, officio, Omega, omitted, ordinary, Organisation, outflow, Pa, par, Parshall, pendency, peripheral, Phenotypically, phosphatase, plc, potent, Priority, prognostic, programmatic, promulgated, properdin, proxy, PRV, pulmonology, Raul, recourse, redirect, registration, relationship, relaunch, remeasurement, renegotiate, rescission, rescissory, Rhythm, satisfaction, segmented, septic, Shield, shock, SLE, speaker, Speed, Stanley, subcontract, tetraplegia, thereof, thereon, timeframe, tissue, transplant, Transplantation, troponin, unaffected, unanimously, unmet, unreasonably, unwind, VIE, visual, Votto, Voucher, waived, waiver, Wang, Warp, weekly, Wei, wild, withheld
Removed:
AB, accident, Aid, AMT, analyzing, ARIMF, art, avoid, back, basket, begun, benchmark, bile, Biliary, bind, bivalent, capitalizing, carryback, CCA, China, circumstance, cloud, collectibility, combine, communicate, conform, conformity, deduct, deduction, delaying, disaggregate, distancing, EAP, educating, enactment, episode, excellence, Fast, France, hosting, hyaluronidase, improvement, inadvertently, indefinitely, inpatient, involuntarily, Island, isolation, jeopardizing, line, live, location, Moderna, morale, NOL, opened, originally, originated, paragraph, petitioned, pneumonia, pool, population, privately, PTO, qualifying, qualitative, quantitative, quarantine, realization, reallocation, reassessed, recoverable, recovering, redesign, regularly, repealed, requirement, reviewed, Rhode, safeguarding, sense, sentence, serum, software, stay, streamline, supportable, task, taxable, Track, transitioning, Trump, understanding, undertook, validate, visible
Filing tables
Filing exhibits
Related press release
ALXN similar filings
Filing view
External links
Exhibit 32.2
CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002
In connection with the quarterly report on Form 10-Q of Alexion Pharmaceuticals, Inc. (the “Company”) for the fiscal quarter ended March 31, 2021 as filed with the Securities and Exchange Commission (the “Report”), I, Aradhana Sarin, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, to my knowledge, that:
(1)the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
(2)the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.
| Dated: | April 30, 2021 | /s/ ARADHANA SARIN, M.D. | |||||||||
| Executive Vice President and Chief Financial Officer | |||||||||||
A signed original of this written statement required by Section 906 has been provided to the Company and will be retained by the Company and furnished to the Securities and Exchange Commission or its staff upon request.